Forecasting antiinfective medicine sales in Germany indicates a steady increase from 2024 to 2028, with values rising from 2.78 billion Euros in 2024 to 2.98 billion Euros by 2028. Compared to 2023, where actual sales data stood as a necessary reference point, the forecasted growth reveals a consistent yearly increase, reflecting stability in market demand.
Year-on-year variations display small but steady growth, underlining resilience in the market. The compound annual growth rate (CAGR) over the reviewed period suggests a gradual yet persistent upward trend.
Future trends to watch in this sector include the impact of technological advancements, emergence of resistance issues, and regulatory changes. Additionally, adapting to healthcare policy shifts and focusing on sustainable practices will be crucial for maintaining growth.
